nobiletin has been researched along with Thyroid Carcinoma, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavaco, BM; Leite, V; Pinto, AT; Pojo, M; Serra, AT; Sousa, DP | 1 |
1 other study(ies) available for nobiletin and Thyroid Carcinoma, Anaplastic
| Article | Year |
|---|---|
Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Cell Survival; Cisplatin; Dietary Supplements; Drug Therapy, Combination; Flavones; Humans; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tumor Cells, Cultured | 2020 |